BMO Capital downgrades Exelon stock rating on regulatory concerns By Investing.com

BMO Capital downgraded Exelon to Market Perform from Outperform and cut its price target to $49 from $52 after PECO withdrew its electric and gas rate cases, citing limited visibility for multiple expansion. Exelon is still guiding for EPS growth near the top end of its 5-7% range through 2029 and has outlined capital redeployment and efficiency measures, but the downgrade and rangebound outlook are a near-term headwind. The stock currently trades at $47.59, and the company continues to support income investors with a 3.53% dividend yield and 56 consecutive years of dividend payments.

Analysis

The market is treating this as a valuation reset, but the deeper issue is mix shift: when a regulated utility loses a visible earnings catalyst, the stock stops trading like a bond proxy with embedded growth and starts trading on allowed-return scrutiny. That tends to compress multiple first, then force management into lower-quality capital allocation choices if they try to defend the growth algorithm too aggressively. The biggest second-order effect is not just on EXC—it’s on any utility with similar regulatory overhangs, because investors will start demanding evidence that rate-base growth can still translate into EPS growth without repeated approvals.

The near-term path for recovery is likely months, not days, and it hinges on whether capital redeployment and project delays can offset the withdrawn cases without pushing out the 2026-2027 earnings bridge. If management can show a credible offset within one or two quarters, the stock can re-rate back toward the mid-point of the newly lowered range; if not, the dividend yield becomes a floor, but not enough to stop multiple compression in a higher-rate environment. The bond issuance also matters: it suggests the balance sheet can absorb some transition pain, but it raises the bar for proving that incremental debt is funding returns above the cost of capital.

The contrarian view is that the selloff may be overdone if investors are extrapolating one regulatory setback into a structural growth problem. Utilities with long dividend histories and low-volatility cash flows often mean-revert once the next catalyst emerges, especially if peers remain tied to rate-case uncertainty. However, the tradeable upside is probably capped unless there is a clear near-term positive surprise on regulatory recovery or project approvals, so this is more of a tactical mean-reversion setup than a durable growth story.

Key Decisions for Investors

• Short EXC into strength over the next 2-6 weeks; target a retrace toward the low end of the revised valuation band. Risk/reward favors a tactical short because the immediate catalyst mix is still negative and the stock likely needs a new earnings catalyst to re-rate.
• If already long utilities, rotate from EXC into higher-quality regulated peers with cleaner regulatory visibility over the next 1-3 months. The relative trade should benefit from capital leaving the ‘story risk’ names and moving into steadier allowed-return compounding.
• Consider an EXC put spread 1-3 months out to express continued multiple compression while limiting premium outlay. Best used if the stock bounces on yield-buying but fundamentals still lack a clear catalyst.
• Watch for a long entry only after management provides a concrete offset plan with quantified EPS bridge and project timing. If that comes through within 1-2 quarters, a mean-reversion long becomes attractive because the dividend should keep downside anchored.
• Use PECO as a sentiment read-through for the broader regulated utility complex; avoid adding to names with pending rate-case dependence until regulatory visibility improves. The second-order risk is sector-wide multiple compression if investors start pricing in more withdrawn or delayed cases.